Dabur India declined 6.03% to Rs 465.60 after the company projected a mid-single-digit decline in its domestic FMCG business, due to delayed and truncated winters as well as slowdown in urban markets.
Dabur is an India-based company that manufactures and markets ayurvedic herbal medicines and consumer products including supplements, cosmetics and beverages for retailers.